Hebei Senlang Biotechnology Inc., Ltd.
Clinical trials sponsored by Hebei Senlang Biotechnology Inc., Ltd., explained in plain language.
-
Scientists test revolutionary cell therapy for untreatable bowel disease
Disease control Recruiting nowThis early-stage study is testing a personalized cell therapy called CAR-T for people with severe ulcerative colitis that hasn't responded to standard medications. Doctors will collect immune cells from 12 participants, modify them in a lab to potentially fight intestinal inflamm…
Phase: EARLY_PHASE1 • Sponsor: Hebei Senlang Biotechnology Inc., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New 'Living Drug' trial offers hope for kids and young adults battling leukemia that Won't quit
Disease control Recruiting nowThis study is testing a personalized cell therapy called Senl_B19 CAR-T for children and young adults (ages 3-25) whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to other treatments. Doctors will collect a patient's own immune cells, genetically modify…
Phase: PHASE2 • Sponsor: Hebei Senlang Biotechnology Inc., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC